Virtus ETF Advisers’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-36,084	Closed	-$324K	–	456
2024 Q4	$324K	Sell	36,084 -25,477	-41%	-$208K	0.13%	235
2024 Q3	$451K	Hold	61,561	–	–	0.21%	188
2024 Q2	$352K	Buy	61,561 +19,366	+46%	+$102K	0.17%	196
2024 Q1	$211K	Buy	42,195 +6,071	+17%	+$41.2K	0.11%	244
2023 Q4	$325K	Buy	36,124 +5,267	+17%	+$43.4K	0.21%	212
2023 Q3	$240K	Sell	30,857 -3,993	-11%	-$39K	0.15%	228
2023 Q2	$337K	Sell	34,850 -31,098	-47%	-$323K	0.2%	172
2023 Q1	$723K	Buy	65,948 +1,162	+2%	+$10.2K	0.4%	122
2022 Q4	$280K	Buy	64,786 +39,866	+160%	+$231K	0.15%	295
2022 Q3	$187K	Buy	24,920 +364	+1%	+$3.15K	0.07%	325
2022 Q2	$247K	Buy	24,556 +3,903	+19%	+$43.6K	0.09%	300
2022 Q1	$256K	Hold	20,653	–	–	0.11%	184
2021 Q4	$472K	Buy	+20,653	New	+$489K	0.18%	120